Synthetic biomarkers identify early cancer
Dr. Kwong’s paper describing how nanoparticles can be used as ‘synthetic biomarkers’ to noninvasively monitor liver fibrosis and detect early stage cancer has been published in Nature Biotechnology. Cheers to all my colleagues and collaborators – we formed a great team!
Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease, Nat. Biotechnol.
Media Coverage:
MIT news: New technology may enable early cancer diagnosis
Phys.org: Nanoparticles amplify tumor signals, making them easier to detect in the urine
Cancer Discovery: Synthetic biomarkers identify early cancer
FierceHealthIT: Nanotechnology enables creation of biomarkers for early cancer detection
AZoNano: Novel nanoparticles for easier biomarker detection
NZZ am Sonntag (German), Nanomedicine, Newsroom America, ProteoMonitor, National Cancer Institute